HBM Healthcare Investments Past Earnings Performance
Past criteria checks 0/6
HBM Healthcare Investments's earnings have been declining at an average annual rate of -38.1%, while the Capital Markets industry saw earnings growing at 8.9% annually. Revenues have been declining at an average rate of 37.9% per year.
Key information
-38.1%
Earnings growth rate
-38.1%
EPS growth rate
| Capital Markets Industry Growth | 10.7% |
| Revenue growth rate | -37.9% |
| Return on equity | -9.6% |
| Net Margin | 102.8% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How HBM Healthcare Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | -145 | -149 | 1 | 0 |
| 30 Sep 23 | -178 | -182 | 1 | 0 |
| 30 Jun 23 | -204 | -209 | 1 | 0 |
| 31 Mar 23 | -142 | -146 | 1 | 0 |
| 31 Dec 22 | -504 | -508 | 1 | 0 |
| 30 Sep 22 | -379 | -383 | 1 | 0 |
| 30 Jun 22 | -158 | -162 | 1 | 0 |
| 31 Mar 22 | -74 | -78 | 1 | 0 |
| 31 Dec 21 | 399 | 387 | 9 | 0 |
| 30 Sep 21 | 598 | 586 | 9 | 0 |
| 30 Jun 21 | 679 | 666 | 9 | 0 |
| 31 Mar 21 | 769 | 756 | 9 | 0 |
| 31 Dec 20 | 567 | 562 | 3 | 0 |
| 30 Sep 20 | 527 | 522 | 3 | 0 |
| 30 Jun 20 | 339 | 333 | 3 | 0 |
| 31 Mar 20 | 189 | 183 | 3 | 0 |
| 31 Dec 19 | 400 | 393 | 3 | 0 |
| 30 Sep 19 | 141 | 135 | 3 | 0 |
| 30 Jun 19 | 224 | 218 | 3 | 0 |
| 31 Mar 19 | 216 | 209 | 3 | 0 |
| 31 Dec 18 | 117 | 112 | 2 | 0 |
| 30 Sep 18 | 285 | 279 | 2 | 0 |
| 30 Jun 18 | 260 | 254 | 2 | 0 |
| 31 Mar 18 | 121 | 116 | 2 | 0 |
| 31 Dec 17 | 248 | 242 | 2 | 0 |
| 30 Sep 17 | 131 | 126 | 2 | 0 |
| 30 Jun 17 | 93 | 88 | 2 | 0 |
| 31 Mar 17 | 142 | 137 | 2 | 0 |
| 31 Dec 16 | -129 | -97 | -20 | 0 |
| 30 Sep 16 | 139 | 156 | -7 | 0 |
| 30 Jun 16 | 40 | 46 | -3 | 0 |
| 31 Mar 16 | 27 | 24 | 1 | 0 |
| 31 Dec 15 | 152 | 122 | 29 | 0 |
| 30 Sep 15 | 74 | 34 | 41 | 0 |
| 30 Jun 15 | 208 | 164 | 52 | 0 |
| 31 Mar 15 | 304 | 258 | 61 | 0 |
| 31 Dec 14 | 410 | 348 | 60 | 0 |
| 30 Sep 14 | 337 | 297 | 38 | 0 |
| 30 Jun 14 | 366 | 338 | 26 | 0 |
| 31 Mar 14 | 371 | 354 | 16 | 0 |
| 31 Dec 13 | 338 | 326 | 11 | 0 |
| 30 Sep 13 | 233 | 221 | 10 | 0 |
| 30 Jun 13 | 117 | 105 | 10 | 0 |
Quality Earnings: HBMN is currently unprofitable.
Growing Profit Margin: HBMN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HBMN is unprofitable, and losses have increased over the past 5 years at a rate of 38.1% per year.
Accelerating Growth: Unable to compare HBMN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HBMN is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (6%).
Return on Equity
High ROE: HBMN has a negative Return on Equity (-9.59%), as it is currently unprofitable.